Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on MY008211A Pharmacokinetics in Healthy Adults
NCT05828485Phase 1Completed
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd.
- Start
- Sep 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of MY-008 in paroxysmal nocturnal hemoglobinuria (PNH) (2 arms), sponsored by Wuhan Createrna Science and Technology Co., Ltd. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration and 1 more. Started Sep 2022; status: completed.
02
Drugs
MY-008
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT05828485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05828485.